Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. 1997

A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
Institute of Pharmacological Sciences, University of Milano, Italy.

Oxidized low density lipoproteins (OxLDL) are toxic to cells of the arterial wall and trigger the expression of the inducible form of hsp 70 in cultured endothelial cells (EAhy-926) and smooth muscle cells (HUVSMC). The latter response is believed to protect cells from toxicity since heat shock protein 70 (hsp70) is synthesized by cells under stress condition to protect proteins from irreversible denaturation. Simvastatin (10(-8) M to 10(-5) M), a competitive inhibitor of hydroxy methyl glutaryl coenzyme A reductase (HMG-CoA reductase), a key enzyme in cholesterol biosynthesis, enhanced the toxicity of OxLDL (300 micrograms/mL) to endothelial cells and smooth muscle cells in a dose-dependent manner, as detected by 3H-adenine release and the MTT test. In EAhy, 3H-adenine release with OxLDL was 0.419 +/- 0.048 (ratio of radioactivity released in the medium to total radioactivity) versus 0.337 +/- 0.008 of control; in the presence of simvastatin and OxLDL this value increased from 0.49 +/- 0.01 at 10(-8) M to 0.918 +/- 0.001 at 10(-5) M with simvastatin alone (10(-5) M) this value was 0.463 +/- 0.025. Furthermore simvastatin reduced in a dose-dependent manner the expression of hsp 70 triggered by OxLDL, as detected by immunoblotting. To address whether this finding was due to the effect of simvastatin on the cholesterol pathway, mevalonate (100 microM) was used to bypass the HMG-CoA reductase block. This compound completely prevented the enhancement of OxLDL toxicity by simvastatin and restored the expression of hsp70. To verify whether cholesterol synthesis was required for the induction of hsp70 by OxLDL, squalestatin I (25 nM to 100 nM), an inhibitor of squalene synthase, another key enzyme of the cholesterol pathway, was used: OxLDL toxicity and hsp70 expression were not affected by this compound. These results indicate that simvastatin increases OxLDL cytotoxicity in vitro with a concomitant decrease of hsp70 expression triggered by OxLDL and that the key step in the cholesterol synthesis responsible for these effects must be between mevalonate and squalene formation.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013186 Farnesyl-Diphosphate Farnesyltransferase The first committed enzyme of the biosynthesis pathway that leads to the production of STEROLS. it catalyzes the synthesis of SQUALENE from farnesyl pyrophosphate via the intermediate PRESQUALENE PYROPHOSPHATE. This enzyme is also a critical branch point enzyme in the biosynthesis of ISOPRENOIDS that is thought to regulate the flux of isoprene intermediates through the sterol pathway. Squalene Synthetase,FPP-FPP Farnesyl Transferase,Farnesyldiphosphate-Farnesyldiphosphate Farnesyltransferase,Presqualene-Diphosphate Synthase,Squalene Synthase,FPP FPP Farnesyl Transferase,Farnesyl Diphosphate Farnesyltransferase,Farnesyl Transferase, FPP-FPP,Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase,Farnesyltransferase, Farnesyl-Diphosphate,Farnesyltransferase, Farnesyldiphosphate-Farnesyldiphosphate,Presqualene Diphosphate Synthase,Synthase, Presqualene-Diphosphate,Synthase, Squalene,Synthetase, Squalene,Transferase, FPP-FPP Farnesyl
D014233 Tricarboxylic Acids Organic compounds that are acyclic and contain three acid groups. A member of this class is citric acid which is the first product formed by reaction of pyruvate and oxaloacetate. (From Lehninger, Principles of Biochemistry, 1982, p443) Tricarboxylic Acid,Acid, Tricarboxylic,Acids, Tricarboxylic

Related Publications

A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
September 2008, Shock (Augusta, Ga.),
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
April 1994, Biochemical and biophysical research communications,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
February 2009, Acta biochimica et biophysica Sinica,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
March 2009, Arteriosclerosis, thrombosis, and vascular biology,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
September 1995, FEBS letters,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
December 1999, Journal of molecular and cellular cardiology,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
March 1979, Atherosclerosis,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
January 2007, Cardiovascular research,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
June 2001, Arteriosclerosis, thrombosis, and vascular biology,
A Pirillo, and C Jacoviello, and C Longoni, and A Radaelli, and A L Catapano
August 2003, Biochemical and biophysical research communications,
Copied contents to your clipboard!